AkzoNobel stock faces UK hurdle in Axalta merger

AkzoNobel stock faces a new regulatory test after the UK Competition and Markets Authority found a realistic prospect of substantially less competition from the planned merger with Axalta. The CMA published its Phase 1 decision on Wednesday, November 11, identifying concerns in the supply of vehicle refinish coatings in the United Kingdom.

The regulator said AkzoNobel and Axalta compete closely in this market, offering similar products, technical support and broad approval coverage with vehicle manufacturers and insurers. The combined company would become the clear UK market leader, with a 40% to 50% share of supply. The CMA warned that customers could face higher prices or lower product quality and support if the competitive overlap disappeared.

The CMA's assessment is preliminary rather than a final finding that the merger would harm competition. The parties have until Wednesday, November 18, 2026, to offer undertakings that address the concern. If no acceptable remedy is offered, the CMA will refer the transaction for an in-depth Phase 2 investigation. The full decision is available from the UK Competition and Markets Authority.

The CMA did not identify significant competition concerns in thermosetting powder coatings in the UK and European Economic Area. It said alternative suppliers and widespread multisourcing would continue to constrain the combined company in that market.

AkzoNobel stock traded at 62.94 euros on Lang & Schwarz at 10:16 CET on Friday, November 13. The proposed transaction remains subject to regulatory review and other closing conditions, making the November 18 remedy deadline the next immediate test for investors.

European coating stocks remain sensitive to merger approvals, regulatory remedies and consolidation expectations. Follow the Euro Stoxx 50 for the broader market backdrop.

More news and analyses on AkzoNobel stock